ABVC vs MSCI · rev $796.0K vs P/E 37, rev $1.72B
ABVC Biopharma Inc (ABVC) versus MSCI Inc (MSCI) — a side-by-side from cached financials, not a winner call.
ABVC Biopharma Inc (ABVC) is a biotechnology company listed on NASDAQ.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Latest reported ABVC revenue for 2025-09-30 was $796.0K. Net income was -$1.3M. ABVC currently screens at market cap $35.9M.
Latest reported MSCI revenue for 2026-06-30 was $1.72B. Net income was $748.0M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
ABVC currently screens at market cap $35.9M. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Not investment advice. Open the ABVC and MSCI stock pages for the full models.
Not investment advice.